1.
Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator...
by Ruilope, Luis Miguel, Prof
The Lancet (British edition), 2010, Vol.375 (9722), p.1255-1266

2.
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
by Böhm, Michael, Prof
The Lancet (British edition), 2017, Vol.389 (10085), p.2226-2237

3.
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
by Thiele, Holger, Prof
The Lancet (British edition), 2013, Vol.382 (9905), p.1638-1645

4.
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
by Böhm, Michael, Prof
The Lancet (British edition), 2010, Vol.376 (9744), p.886-894

5.
Ocular hypotony in patients with juvenile idiopathic arthritis – associated uveitis
by Böhm, Michael R.R
American journal of ophthalmology, 2016, Vol.173, p.45-55

6.
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
by Esler, Murray D
The Lancet (British edition), 2010, Vol.376 (9756), p.1903-1909

7.
Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis
by Breitbach, Marc
Graefe's archive for clinical and experimental ophthalmology, 2016-09-30, Vol.255 (1), p.171-177

8.
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Tr...
by Böhm, Michael, MD
The American journal of cardiology, 2015, Vol.116 (12), p.1890-1897

9.
Overestimation of cardiovascular outcome incidence – Authors' reply
by Schumacher, Helmut
The Lancet (British edition), 2017-12-09, Vol.390 (10112), p.2547-2547

10.
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
by Swedberg, Karl, Prof
The Lancet (British edition), 2010, Vol.376 (9744), p.875-885

11.
Cardiovascular remodelling in coronary artery disease and heart failure
by Heusch, Gerd, Prof
The Lancet (British edition), 2014, Vol.383 (9932), p.1933-1943

12.
MANAGEMENT OF END STAGE HEART FAILURE
by Friedrich, Erik B
Heart (British Cardiac Society), 2007-05, Vol.93 (5), p.626-631

13.
Effects of crystallin-β-b2 on stressed RPE in vitro and in vivo
by Böhm, Michael R. R
Graefe's archive for clinical and experimental ophthalmology, 2012-10-17, Vol.251 (1), p.63-79

14.
Prevention of restenosis: is angioplasty the answer?
by Scheller, Bruno
Heart (British Cardiac Society), 2007-05, Vol.93 (5), p.539-541

15.
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study
by Krum, Henry, Prof
The Lancet (British edition), 2014, Vol.383 (9917), p.622-629

16.
Hydration and contrast-induced kidney injury
by Schwarz, Viktoria
The Lancet (British edition), 2017-07-29, Vol.390 (10093), p.452-452

17.
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (...
by Thiele, Holger, MD
The American heart journal, 2012, Vol.163 (6), p.938-945

18.
Assessing perinatal depression as an indicator of risk for pregnancy-associated cardiovascular disease
by Nicholson, L
Cardiovascular Journal of Africa, 2016-05-18, Vol.27 (2), p.119-122

19.
Percutaneous renal denervation: new treatment option for resistant hypertension and more?
by Ewen, Sebastian
Heart (British Cardiac Society), 2013-08, Vol.99 (15), p.1129-1134

20.
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihype...
by Kandzari, David E., MD
The American heart journal, 2015, Vol.171 (1), p.82-91
